On the evening of April 25, Shandong Pharmaceutical Glass Co.Ltd(600529) ( Shandong Pharmaceutical Glass Co.Ltd(600529) ) released the first quarter report of 2022. During the reporting period, the company achieved an operating revenue of 1.042 billion yuan, a year-on-year increase of 12.53%; The net profit attributable to the shareholders of the listed company was 153 million yuan, a year-on-year decrease of 1.93%; The net profit attributable to shareholders of listed companies after deducting non recurring profits and losses was 152 million yuan, a year-on-year decrease of 2.72%; The basic earnings per share is 0.26 yuan / share.